The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ridate Plus Ca & D 35 mg Film-Coated Tablets + 1000 mg/880 IU Effervescent Tablets



Rowex LtdPA0711/191/001

Main Information

Trade NameRidate Plus Ca & D 35 mg Film-Coated Tablets + 1000 mg/880 IU Effervescent Tablets
Active SubstancesCalcium carbonate
Cholecalciferol
Risedronate sodium
Dosage FormEffervescent tablet + film-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/191/001

Group Information

ATC CodeM05BB Bisphosphonates, combinations
M05BB04 risedronic acid, calcium and colecalciferol, sequential

Status

License statusAuthorised
Licence Issued30/03/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back